Tildren 5 mg/ml 10 x 10 ml
Le numéro d’autorisation de mise sur le marché de votre pays ne pas répertorié ? Il s'agit alors d'un produit cascade. Cliquez ici pour plus d'informations.
En stock
Tildren 5 mg/ml 10 x 10 ml
To aid in the treatment of lameness associated with osteolytic processes observed in bone spavin and in navicular syndrome of less than 6 months.
Composition
The powder contains: Tiludronic Acid (as disodium Acid) 50 mg.
The solvent vial contains: water for injection 10 ml.
The solution after reconstitution contains: Tiludronic acid 5 mg/m
Indications d'utilisation
0.1 mg of tiludronic acid per kg of body weight per day for 10 days by slow intravenous route, i.e. 1 ml per 50 kg of body weight per day of a reconstituted solution containing 5 mg/ml of tiludronic acid.
The reconstituted solution is obtained by adding under aseptic conditions the solvent to the powder and gently mixing them.
- The product should be administered over 20 to 30 seconds for 10 ml.
- The side of the site of injection must be alternated from day to day.
- The product should be used immediately and not stored after reconstitution.
- Do not exceed the recommended dosage.